Imedisync
Seoul, KR · 1 known investors
Find your way into Imedisync
Sign up to find every way you can get introduced to Imedisync
- Your email: who you already know at Imedisync, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Imedisync team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
iMediSync develops AI and machine learning-based diagnostic platforms for neuropsychiatric and brain disorders, including tools for early dementia detection and Parkinson's disease classification. The company serves healthcare providers and institutions with FDA-approved software medical devices and wearable technology.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Imedisync do?
- iMediSync develops AI and machine learning-based diagnostic platforms for neuropsychiatric and brain disorders, including tools for early dementia detection and Parkinson's disease classification. The company serves healthcare providers and institutions with FDA-approved software medical devices and wearable technology.
- Who founded Imedisync?
- Imedisync was founded by 강승완 (Seung-Wan Kang).
- Who are Imedisync's investors?
- Imedisync's investors include Aju IB Invesment Corporation.
- Where is Imedisync headquartered?
- Imedisync is headquartered in Seoul, KR.

